Literature DB >> 11438625

Electrocardiographically gated blood-pool SPECT and left ventricular function: comparative value of 3 methods for ejection fraction and volume estimation.

D Daou1, F Harel, B O Helal, T Fourme, P Colin, R Lebtahi, D Mariano-Goulart, M Faraggi, M Slama, D Le Guludec.   

Abstract

UNLABELLED: The current major limitation to development of electrocardiographically (ECG) gated blood-pool SPECT (GBPS) for measurement of the left ventricular (LV) ejection fraction (LVEF) and volumes is the lack of availability of clinically validated automatic processing software. Recently, 2 processing software methods for quantification of the LV function have been described. Their LVEFs have been validated separately, but no validation of the LV volume measurement has been reported.
METHODS: We compared 3 processing methods for evaluation of the LVEF (n = 29) and volumes (n = 58) in 29 patients: automatic geometric method (GBPS(G)), semiautomatic activity method (GBPS(M)), and 35% maximal activity manual method (GBPS(35%)). The LVEF provided by the ECG gated equilibrium planar left anterior oblique view (planar(LAO)) and the LV volumes provided by LV digital angiography (Rx) were used as gold standards.
RESULTS: Whereas the GBPS(G) and GBPS(M) methods present similar low percentage variabilities, the GBPS(35%) method provided the lowest percentage variabilities for the LVEF and volume measurements (P < 0.04 and P < 0.02, respectively). The LVEF and volume provided by the 3 methods were highly correlated with the gold standard methods (r > 0.98 and r > 0.83, respectively). The LVEFs provided by the GBPS(35%) and GBPS(M) methods are similar and higher than those of the GBPS(G) method and planar(LAO) method, respectively (P < 0.0001). For the LVEF, there is no correlation between the average and paired absolute difference for the 3 GBPS methods against the planar(LAO) method, and the limits of agreement are relatively large. LV volumes are lower when calculated with the GBPS(M), GBPS(G), and Rx methods (P < 0.0001). However, the GBPS(35%) and Rx methods provide LV volumes that are similar. There is no linear correlation between the average and the paired absolute difference of volumes calculated with the GBPS(G) and GBPS(35%) methods against Rx LV volumes. However, a moderate linear correlation was found with the GBPS(M) method (r = 0.6; P = 0.0001). The 95% limits of agreement between the Rx LV volumes and the 3 GBPS methods are relatively large.
CONCLUSION: GBPS is a simple, highly reproducible, and accurate technique for the LVEF and volume measurement. The reported findings should be considered when comparing results of different methods (GBPS vs. planar(LAO) LVEF; GBPS vs. Rx volume) and results of different GBPS processing methods.

Entities:  

Mesh:

Year:  2001        PMID: 11438625

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  17 in total

1.  Comparative value of ECG-gated blood pool SPET and ECG-gated myocardial perfusion SPET in the assessment of global systolic left ventricular function.

Authors:  Doumit Daou; Didier Vilain; Patrice Colin; Rachida Lebtahi; Thierry Fourme; Carlos Coaguila; Abdel Benada; Ilana Idy-Peretti; Michel Slama; Dominique Le Guludec
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-04-04       Impact factor: 9.236

2.  Automatic quantification of right ventricular function with gated blood pool SPECT.

Authors:  Doumit Daou; Serge D Van Kriekinge; Carlos Coaguila; Rachida Lebtahi; Thierry Fourme; Olivier Sitbon; Florence Parent; Michel Slama; Dominique Le Guludec; Gerald Simonneau
Journal:  J Nucl Cardiol       Date:  2004 May-Jun       Impact factor: 5.952

3.  Model dependence of gated blood pool SPECT ventricular function measurements.

Authors:  Kenneth Nichols; Naeem Humayun; Pieter De Bondt; Stijn Vandenberghe; Olakunle O Akinboboye; Steven R Bergmann
Journal:  J Nucl Cardiol       Date:  2004 May-Jun       Impact factor: 5.952

4.  Clinical validation of the gated blood pool SPECT QBS processing software in congestive heart failure patients: correlation with MUGA, first-pass RNV and 2D-echocardiography.

Authors:  Marcus Hacker; Xaver Hoyer; Sandra Kupzyk; Christian La Fougere; Johann Kois; Hans-Ulrich Stempfle; Reinhold Tiling; Klaus Hahn; Stefan Störk
Journal:  Int J Cardiovasc Imaging       Date:  2005-11-22       Impact factor: 2.357

Review 5.  SPECT radionuclide angiography: it is time for a consensus statement.

Authors:  Doumit Daou
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-11       Impact factor: 9.236

6.  Operator-interactive method for simultaneous measurement of left and right ventricular volumes and ejection fraction by tomographic electrocardiography-gated blood pool radionuclide ventriculography.

Authors:  Ian P Clements; Benjamin Brinkmann; Brian P Mullan; Michael K O'Connor; Jerome F Breen; Christopher G A McGregor
Journal:  J Nucl Cardiol       Date:  2006 Jan-Feb       Impact factor: 5.952

Review 7.  Cardiotoxicity due to chemotherapy: role of cardiac imaging.

Authors:  Frédéric Poulin; Paaladinesh Thavendiranathan
Journal:  Curr Cardiol Rep       Date:  2015-03       Impact factor: 2.931

8.  Assessment of pulmonary thromboendarterectomy by tomographic electrocardiogram-gated equilibrium radionuclide angiocardiography compared with electron beam computed tomography.

Authors:  Ian P Clements; Brian P Mullan; Michael K O'Connor; Jerome F Breen; Christopher G A McGregor
Journal:  J Nucl Cardiol       Date:  2007-01       Impact factor: 5.952

9.  Influence of CT-based attenuation correction in assessment of left and right ventricular functions with count-based gated blood-pool SPECT.

Authors:  Louis Sibille; Fayçal Ben Bouallegue; Aurélie Bourdon; Denis Mariano-Goulart
Journal:  J Nucl Cardiol       Date:  2011-06-07       Impact factor: 5.952

10.  Comparison of interstudy reproducibility of equilibrium electrocardiography-gated SPECT radionuclide angiography versus planar radionuclide angiography for the quantification of global left ventricular function.

Authors:  Doumit Daou; Carlos Coaguila; Abdel Benada
Journal:  J Nucl Cardiol       Date:  2006 Mar-Apr       Impact factor: 5.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.